Andrea Kelley Cyr, D.O. Physical Medicine & Rehabilitation - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 1260 City Center Drive, Carmel, IN 46032 Phone: 214-970-6817 |
Michael Alan Murphy, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1980 E 116th St Ste 315, Carmel, IN 46032 Phone: 317-350-4060 |
Ralph Buschbacher, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5891 Tall Timber Run, Carmel, IN 46033 Phone: 317-679-7806 Fax: 317-582-1669 |
Michelle Ortega, Physical Medicine & Rehabilitation - Hospice and Palliative Medicine Medicare: Not Enrolled in Medicare Practice Location: 130 W Carmel Dr, Carmel, IN 46032 Phone: 555-555-5555 |
Kristen Steele, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2190 Seasons North Dr Unit 211, Carmel, IN 46280 Phone: 423-363-5040 |
Michael Joseph Del Busto Jr., MD Physical Medicine & Rehabilitation - Sports Medicine Medicare: Medicare Enrolled Practice Location: 10767 Illinois St Ste 3000, Carmel, IN 46032 Phone: 317-817-1200 Fax: 317-817-1220 |
News Archive
This past summer saw a revolution in melanoma therapy. Patients whose melanoma lesions contain a mutation in the BRAF gene were successfully treated with a BRAF-specific inhibitor, PLX4032. Reports of the drug trial described shrinking tumors and improved health. Yet seven months after therapy began the tumors returned and resumed growing. Now, scientists at The Wistar Institute explain why: the tumor learns to signal around the blocked gene by adjusting its molecular wiring.
Especially at longer follow-up times, overweight and obesity are associated with chronic disease risks for survivors of moderate to severe traumatic brain injury, reports a study in the July/August issue of the Journal of Head Trauma Rehabilitation.
Up to 22 percent of surgical patients experience unexpected complications and must be readmitted for post-operative care. A study led by the University of Utah suggests that returning to the same hospital is important for recovery. Readmission to a different hospital was associated with a 26 percent increased risk for dying within 90 days.
Abbott today announced that the XIENCE Xpedition Everolimus Eluting Coronary Stent System received U.S. Food and Drug Administration (FDA) approval and is launching immediately in the United States, providing physicians with a next-generation technology with the largest size matrix in the U.S. market.
Nearly all U.S. states offer the human papillomavirus vaccine to adolescent girls who have been arrested or detained, according to a new report from The Miriam Hospital and Brown University. The study, published in the May issue of the Journal of Adolescent Health, offers the first nationwide review of HPV vaccination practices among juvenile justice facilities.
› Verified 4 days ago